Global Health Ventures To Initiate Human Clinical Trials In Europe For X-Excite, Its Male Sexual Enhancement Drug

Global Health Ventures Inc. (OTCBB:GHLV), or the “Company”, is pleased to announce that it has engaged Clinical Investigations Ltd. of United Kingdom to design and carry out the human clinical trials for X-Excite in Europe under the European Regulatory Guidelines (EMEA)…

Related posts:

  1. Gay And Lesbian Patients Excluded From Some Clinical Trials
  2. Also In Global Health News: HIV Vaccine; Chile To Provide Free ‘Emergency Contraception’; China Indoor Smoking Ban; Malaria Clinical Trials

0 Comments. Posted by Luv2Play on Thursday, February 25, 2010 at 9:36 pm.

Filed under STD's.

No Comments on “Global Health Ventures To Initiate Human Clinical Trials In Europe For X-Excite, Its Male Sexual Enhancement Drug”

You can track this conversation through its atom feed.

No one has commented on this entry yet.

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>